AVRO
Price
$1.28
Change
+$0.02 (+1.59%)
Updated
Mar 28, 6:59 PM EST
42 days until earnings call
XNCR
Price
$22.13
Change
-$0.29 (-1.29%)
Updated
Mar 28, 6:59 PM EST
42 days until earnings call
Ad is loading...

Compare predictions AVRO vs XNCR

Header iconAVRO vs XNCR Comparison
Open Charts AVRO vs XNCRBanner chart's image
AVROBIO
Price$1.28
Change+$0.02 (+1.59%)
Volume$79.95K
CapitalizationN/A
Xencor
Price$22.13
Change-$0.29 (-1.29%)
Volume$286.33K
CapitalizationN/A
View a ticker or compare two or three
AVRO vs XNCR Comparison Chart

Loading...

AVRODaily Signal changed days agoGain/Loss if shorted
 
Show more...
XNCRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AVRO vs. XNCR commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVRO is a Hold and XNCR is a Buy.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (AVRO: $1.29 vs. XNCR: $22.10)
Brand notoriety: AVRO and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVRO: 29% vs. XNCR: 55%
Market capitalization -- AVRO: $57.87M vs. XNCR: $1.35B
AVRO [@Biotechnology] is valued at $57.87M. XNCR’s [@Biotechnology] market capitalization is $1.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVRO’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • AVRO’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, AVRO is a better buy in the long-term than XNCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVRO’s TA Score shows that 3 TA indicator(s) are bullish while XNCR’s TA Score has 6 bullish TA indicator(s).

  • AVRO’s TA Score: 3 bullish, 5 bearish.
  • XNCR’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than AVRO.

Price Growth

AVRO (@Biotechnology) experienced а +3.20% price change this week, while XNCR (@Biotechnology) price change was -3.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

AVRO is expected to report earnings on May 09, 2024.

XNCR is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AVRO with price predictions.
OPEN
A.I.dvisor published
a Summary for XNCR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
XNCR($1.35B) has a higher market cap than AVRO($57.9M). XNCR has higher P/E ratio than AVRO: XNCR (72.46) vs AVRO (4.78). XNCR YTD gains are higher at: 4.239 vs. AVRO (-5.882). AVRO has higher annual earnings (EBITDA): -71.05M vs. XNCR (-127.14M). XNCR has more cash in the bank: 594M vs. AVRO (98M). AVRO has less debt than XNCR: AVRO (878K) vs XNCR (83.4M). XNCR has higher revenues than AVRO: XNCR (168M) vs AVRO (0).
AVROXNCRAVRO / XNCR
Capitalization57.9M1.35B4%
EBITDA-71.05M-127.14M56%
Gain YTD-5.8824.239-139%
P/E Ratio4.7872.467%
Revenue0168M-
Total Cash98M594M16%
Total Debt878K83.4M1%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVROXNCR
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
68%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 29 days ago
81%
Bullish Trend 9 days ago
70%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Ad is loading...
AVRODaily Signal changed days agoGain/Loss if shorted
 
Show more...
XNCRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBF57.561.48
+2.65%
PBF Energy
WFC57.950.34
+0.59%
Wells Fargo & Co
GBX52.120.18
+0.35%
Greenbrier Companies (The)
LPTH1.38-0.03
-2.41%
LightPath Technologies
LYRA6.22-0.31
-4.75%
Lyra Therapeutics

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-1.34%
BEAM - XNCR
54%
Loosely correlated
-2.82%
PRME - XNCR
53%
Loosely correlated
+3.40%
VCYT - XNCR
52%
Loosely correlated
+2.03%
DNLI - XNCR
52%
Loosely correlated
-1.20%
NTLA - XNCR
51%
Loosely correlated
+1.89%
More